22）Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7): 672–83. 23）Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355(10): 992–1005.24）Jessica Tr, Liam D, Sailesh K. Oral sildenafil citrate during labor mitigates the intrapartum decline in placental growth factor in term pregnancies. Am J Obstet Gynecol 2020; 223(4): 588-90.9219）Walton RB, Reed LC, Estrada SM, Schmiedecke SS, Villazana-Kretzer DL, Napolitano PG, et al. Evaluation of sildenafil and tadalafil for reversing constriction of fetal arteries in a human placenta perfusion model. Hypertension 2018; 72(1). 167-76.20）Nakayama T, Arai K, Sato K, Yanaihara T, Nagatomi K. Pathway of the formation of estriol in the fetoplacental unit. Endocrinol Jpn 1968; 15(2): 255-7.21）Walker WH, Fitzpatrick SL, Barrera-Saldaña HA, Resendez-Perez D, Saunders GF. The human placental lactogen genes: structure, function, evolution and transcriptional regulation. Endocr Rev 1991; 12(4): 316-28.
元のページ ../index.html#106